Pipeline

RAPTOR AI™

In-house Pipeline
: IIT
: SIT
Pipeline
Indication
Pipeline Indication in silico in vitro in vivo IND clinical trials
OC101 Liver Cirrhosis
OC101
Liver Cirrhosis
OC101+OC111 NASH
OC101+OC111
NASH
OC201+OC202e Inhibition of Cancer Metastasis
OC201+OC202e
Inhibition of Cancer Metastasis
OC211 Pan-KRAS Inhibitor
OC211
Pan-KRAS Inhibitor
OC221 Immuno-Oncology Combi
OC221
Immuno-Oncology Combi
OC514 Multiple Muscular Diseases
OC514
Multiple Muscular Diseases
(Sarcopenia, ALS, DMD)
(Sarcopenia, ALS, DMD)
OC701 Atopic Dermatitis
OC701
Atopic Dermatitis
Partnered Pipeline
Pipeline Indication in silico in vitro in vivo IND clinical trials
OJP3101 Metabolic Disease
OJP3101
Metabolic Disease
OJP3101 Cardiovascular Disease
OJP3101
Cardiovascular Disease
OJP4301 Confidential
OJP4301
Confidential
OGP4201 Confidential
OGP4201
Confidential
ODP9401 Metabolic Disease
ODP9401
Metabolic Disease

ONCO-RAPTOR AI™

Pipeline
Indication
Pipeline Indication in silico in vitro in vivo IND clinical trials
ODP2201 Oncology
ODP2201
Oncology
ODP2301 Oncology
ODP2301
Oncology
OSP2401 Oncology
OSP2401
Oncology

ONCOfind AI™

: IIT
: SIT
Pipeline
Pipeline in silico in vitro in vivo IND clinical trials
Carcinoma of Unknown Primary (CUP)
Identification Screening Platform
Carcinoma of Unknown Primary (CUP) Identification Screening Platform